Blend Labs Inc (NYSE:BLND)’s traded shares stood at 2.67 million during the last session, with the company’s beta value hitting 1.25. At the close of trading, the stock’s price was $4.36, to imply a decrease of -4.18% or -$0.19 in intraday trading. The BLND share’s 52-week high remains $4.84, putting it -11.01% down since that peak but still an impressive 73.39% since price per share fell to its 52-week low of $1.16. The company has a valuation of $1.12B, with an average of 2.71 million shares in intraday trading volume over the past 10 days and average of 2.65 million shares over the past 3 months.

Analysts have given a consensus recommendation of Buy for Blend Labs Inc (BLND), translating to a mean rating of 1.67. Of 3 analyst(s) looking at the stock, 0 analyst(s) give BLND a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.01.

Blend Labs Inc (NYSE:BLND) trade information

After registering a -4.18% downside in the last session, Blend Labs Inc (BLND) has traded red over the past five days. The 5-day price performance for the stock is 12.95%, and 11.79% over 30 days. With these gigs, the year-to-date price performance is 70.98%. Short interest in Blend Labs Inc (NYSE:BLND) saw shorts transact 12.73 million shares and set a 8.93 days time to cover.

The extremes give us $4.75 and $10 for target low and target high price respectively. As such, BLND has been trading -129.36% off suggested target high and -8.94% from its likely low.

Blend Labs Inc (BLND) estimates and forecasts

Looking at statistics comparing Blend Labs Inc share performance against respective industry, we note that the company has outperformed competitors. Blend Labs Inc (BLND) shares are 40.19% up over the last 6 months, with its year-to-date growth rate higher than industry average at 82.50% against 22.90%. Revenue is forecast to grow 107.50% this quarter before jumping 106.03% for the next one. The rating firms project that company’s revenue will grow 3.28% compared to the previous financial year.

Revenue forecast for the current quarter as set by 6 analysts is 41.38M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 42.79M.Earnings reports from the last fiscal year show that sales brought in 36.1M and 34.95M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 14.62% before jumping 22.45% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -19.48% for the past 5-year period. While 2024 is set for a 82.05% return in earnings, projections for the next 5 years are at 20.00% annually.

BLND Dividends

Blend Labs Inc has its next earnings report out on 2024-Nov-06. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Blend Labs Inc (NYSE:BLND)’s Major holders

Blend Labs Inc insiders hold 4.10% of total outstanding shares, with institutional holders owning 60.47% of the shares at 63.05% float percentage. In total, 60.47% institutions holds shares in the company, led by GENERAL ATLANTIC, L.P.. As of 2024-06-30, the company held over 19.13 million shares (or 7.6246% of shares), all amounting to roughly $45.15 million.

The next major institution holding the largest number of shares is VANGUARD GROUP INC with 14.81 million shares, or about 5.9027% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $34.96 million.